Parkinson's disease: major drug trial results to watch in 2022
Four clinical trials in Parkinson’s disease with readouts 2H 2022 target motor symptom fluctuations and cognitive impairment.
Stay updated with breaking news from Processing Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Four clinical trials in Parkinson’s disease with readouts 2H 2022 target motor symptom fluctuations and cognitive impairment.
CNS Fujian, China's recently unveiled aircraft carrier, represents the country's latest achievement in its naval hardware construction and incorporates a wide variety of advanced technologies.
Apart from pancreatic ductal adenocarcinoma, studies in liver disease, venous leg ulcer, sleep apnoea, and ocular issues are also reviewed.
Cerevance CMO Jordan Dubow shares exclusive details on the first of two planned registrational trials in Parkinson’s disease.
There are 100–400 million Dengue fever infections each year, and cases are quickly rising. How can manufacturers develop reliable antivirals and vaccines?